PhosphoLean NOPE + EGCG is a patented appetite suppressant compound that is clinically proven to help people stay on their diets.
PhosphoLean NOPE + EGCG is a patented appetite suppressant compound that is clinically proven to help people stay on their diets. PhosphoLean signals the brain to switch off the sensations of hunger and helps individuals manage their stressful diets and lower diet depression. PhosphoLean can be a keynote ingredient for a company’s next weight-management product.
Chemi Nutra
Booth 138
The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN
January 29th 2025The recent CRN webinar discussed GLP-1 medications' impact on supplements, functional foods, and retail, covering consumer trends, global market insights, retailer strategies, industry implications, and future opportunities for innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.